Investing.com - Shares of CombiMatrix Corp (NASDAQ:CBMX) rallied on Tuesday and were up about 40% on the home stretch to the closing bell with investors cheering a proposed merger of the company with ...
IRVINE, Calif., April 7, 2011 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics laboratory offering genetic array testing, a comprehensive profiling of chromosomes and ...
At CombiMatrix Corp., a diagnostic laboratory in Irvine, white-cloaked techs sit hunched over microscopes while their gloved hands deftly pick through the remains of lost pregnancies, pulling the ...
It’s a little discussed fact that many pregnancies end in miscarriage – and it can be hard to understand why. CombiMatrix, an Orange County-based fetal diagnostic company, has developed a microarray ...
CombiMatrix Corp (NASDAQ: CBMX), a molecular diagnostics company, announced on Thursday it has begun to explore strategic alternatives, including potential M&A activity and business development ...
IRVINE, Calif., Nov. 3, 2010 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) announced today that it will release its third quarter 2010 financial results on Wednesday, November 10, 2010.
Acacia Research Corporation has announced that its CombiMatrix has entered into a manufacturing-and-distribution agreement with Macrogen, Inc. The agreement establishes Macrogen as a key distributor ...
Invitae has agreed to acquire two diagnostics developers, CombiMatrix and Good Start Genetics, for a combined $72 million in cash and stock, in a deal designed to expand the buyer’s diagnostics ...
Irvine-based CombiMatrix Corp.’s shares jumped on Thursday after a report on the Seeking Alpha investor website suggested that its stock price will double by the end of the month. Shares of the ...
Earlier this afternoon CombiMatrix issued financial results for the 2017 first quarter. If you've not received this news release or would be like to be added to the company's email distribution list, ...
To significantly cut operating costs CEO to step down as part of restructuring Co to begin search for new CEO April 19 (Reuters) - Biotechnology firm CombiMatrix Corp said its chief executive officer ...
CombiMatrix Corporation (NASDAQ:CBMX) announced today that it has received a four year contract for $858,298 from NASA’s Ames Research Center to design and test a microfluidic system that incorporates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results